Literature DB >> 20679336

Transcriptional regulation by p53.

Rachel Beckerman1, Carol Prives.   

Abstract

Inactivation of p53 is critical for the formation of most tumors. Illumination of the key function(s) of p53 protein in protecting cells from becoming cancerous is therefore a worthy goal. Arguably p53's most important function is to act as a transcription factor that directly regulates perhaps several hundred of the cell's RNA polymerase II (RNAP II)-transcribed genes, and indirectly regulates thousands of others. Indeed p53 is the most well studied mammalian transcription factor. The p53 tetramer binds to its response element where it can recruit diverse transcriptional coregulators such as histone modifying enzymes, chromatin remodeling factors, subunits of the mediator complex, and components of general transcription machinery and preinitiation complex (PIC) to modulate RNAPII activity at target loci (Laptenko and Prives 2006). The p53 transcriptional program is regulated in a stimulus-specific fashion (Murray-Zmijewski et al. 2008; Vousden and Prives 2009), whereby distinct subsets of p53 target genes are induced in response to different p53-activating agents, likely allowing cells to tailor their response to different types of stress. How p53 is able to discriminate between these different loci is the subject of intense research. Here, we describe key aspects of the fundamentals of p53-mediated transcriptional regulation and target gene promoter selectivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679336      PMCID: PMC2908772          DOI: 10.1101/cshperspect.a000935

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  176 in total

1.  BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.

Authors:  Timothy K MacLachlan; Rishu Takimoto; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.

Authors:  Joan Seoane; Hong-Van Le; Joan Massagué
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

3.  The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.

Authors:  Hongwu Zheng; Han You; Xiao Zhen Zhou; Stephen A Murray; Takafumi Uchida; Gerburg Wulf; Ling Gu; Xiaoren Tang; Kun Ping Lu; Zhi-Xiong Jim Xiao
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

4.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 6.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

7.  The IARC TP53 database: new online mutation analysis and recommendations to users.

Authors:  Magali Olivier; Ros Eeles; Monica Hollstein; Mohammed A Khan; Curtis C Harris; Pierre Hainaut
Journal:  Hum Mutat       Date:  2002-06       Impact factor: 4.878

8.  Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation.

Authors:  Axel Weber; Judith Marquardt; David Elzi; Nicole Forster; Sven Starke; Andre Glaum; Daisuke Yamada; Pierre-Antoine Defossez; Jeffrey Delrow; Robert N Eisenman; Holger Christiansen; Martin Eilers
Journal:  EMBO J       Date:  2008-05-01       Impact factor: 11.598

9.  The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.

Authors:  S K Balakrishnan; D S Gross
Journal:  Oncogene       Date:  2007-11-19       Impact factor: 9.867

10.  p53-Induced DNA bending: the interplay between p53-DNA and p53-p53 interactions.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2008-05-08       Impact factor: 2.991

View more
  275 in total

1.  MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Authors:  Lynn Biderman; Masha V Poyurovsky; Yael Assia; James L Manley; Carol Prives
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

2.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 3.  Multifaceted functions of Siva-1: more than an Indian God of Destruction.

Authors:  Yide Mei; Mian Wu
Journal:  Protein Cell       Date:  2012-03-17       Impact factor: 14.870

4.  Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-21       Impact factor: 11.205

5.  TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.

Authors:  Ryo Maeda; Hiroyuki Tamashiro; Kazunori Takano; Hiro Takahashi; Hidefumi Suzuki; Shinta Saito; Waka Kojima; Noritaka Adachi; Kiyoe Ura; Takeshi Endo; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

6.  Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.

Authors:  Jean-Pierre Gillet; Anna Maria Calcagno; Sudhir Varma; Miguel Marino; Lisa J Green; Meena I Vora; Chirayu Patel; Josiah N Orina; Tatiana A Eliseeva; Vineet Singal; Raji Padmanabhan; Ben Davidson; Ram Ganapathi; Anil K Sood; Bo R Rueda; Suresh V Ambudkar; Michael M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-08       Impact factor: 11.205

7.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

8.  Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.

Authors:  Xiaolei Xie; Guangan He; Zahid H Siddik
Journal:  Mol Pharmacol       Date:  2020-02-16       Impact factor: 4.436

9.  mTORC1 and p53: clash of the gods?

Authors:  Paul Hasty; Zelton Dave Sharp; Tyler J Curiel; Judith Campisi
Journal:  Cell Cycle       Date:  2013-01-01       Impact factor: 4.534

Review 10.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.